Search filters

List of works by Craig I Coleman

Agreement between coding schemas used to identify bleeding-related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients.

scientific article published on 23 January 2018

Anticoagulation for the Treatment of Cancer-Associated Thrombosis: A Systematic Review and Network Meta-Analysis of Randomized Trials

scientific article published on 24 September 2018

CRT-D Therapy in Patients with Decompensated NYHA Class-Four CHF

scientific article published on July 30, 2012

Chapter 8: Meta-analysis of Test Performance When There is a “Gold Standard”

scientific article published on June 1, 2012

College and School of Pharmacy Characteristics Associated With US News and World Report Rankings

scientific article published on April 12, 2013

Comparative Risk of Major Bleeding with Rivaroxaban and Warfarin: Population Based Cohort Study of Unprovoked Venous Thromboembolism

scientific article published on 20 November 2018

Contribution of intangible costs to the economic burden of multiple sclerosis

scientific article published on October 18, 2010

Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation

scientific article published on October 9, 2012

Cost-Effectiveness of Universal and Platelet Reactivity Assay-Driven Antiplatelet Therapy in Acute Coronary Syndrome

scientific article published on April 27, 2013

Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States

scientific article published on May 24, 2012

Dosing Frequency and Medication Adherence in Chronic Disease

scientific article published on September 1, 2012

Effect of Topiramate on Weight Gain in Patients Receiving Atypical Antipsychotic Agents

scientific article published on February 1, 2013

Effect of dosing frequency on chronic cardiovascular disease medication adherence

scientific article published on April 5, 2012

Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation

scientific article published on October 31, 2011

Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes

scientific article published on 11 June 2019

Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data

scientific article published on 29 April 2020

Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data

scientific article published on 25 June 2020

Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism

scientific article published on 01 October 2018

Effectiveness and safety of rivaroxaban vs warfarin in people with non-valvular atrial fibrillation and diabetes: an administrative claims database analysis

scientific article published on 16 April 2018

Efficacy of statins in combination with interferon therapy in multiple sclerosis: A meta-analysis

scientific article published on September 1, 2012

Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients

scientific article published on June 26, 2013

Feverfew for Migraine Prophylaxis: A Systematic Review

scientific article published on January 1, 2009

Green Tea Catechins Decrease Total and Low-Density Lipoprotein Cholesterol: A Systematic Review and Meta-Analysis

scientific article published on November 1, 2011

Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis

scientific article published on 31 October 2020

Impact of Mobility Impairment on Indirect Costs and Health-Related Quality of Life in Multiple Sclerosis

scientific article published on January 23, 2013

Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria

scientific article published on 22 August 2019

Impact of non-medical switching of prescription medications on health outcomes: an e-survey of high-volume medicare and medicaid physician providers

scientific article published on 05 October 2020

Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation

scientific article published on 28 January 2019

Intent to Update Systematic Reviews: Results of an Internet Survey

scientific article published on June 1, 2011

Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis

scientific article published on November 23, 2011

Neurothrombectomy Devices for the Treatment of Acute Ischemic Stroke: State of the Evidence

scientific article published on January 17, 2011

Oral anti‐diabetic drugs for the prevention of Type 2 diabetes

scientific article published on August 1, 2011

Physicians' perspectives regarding non-medical switching of prescription medications: Results of an internet e-survey

scientific article published on 10 January 2020

Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism.

scientific article published in January 2018

Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis

scientific article published on February 3, 2012

Proportion of US Hospitalized Medically Ill Patients Who May Qualify for Extended Thromboprophylaxis

scientific article published on 01 January 2019

Real-world management of oral factor Xa inhibitor-related bleeds with reversal or replacement agents including andexanet alfa and four-factor prothrombin complex concentrate: a multicenter study

scientific article published on 03 July 2020

Recombinant Human Growth Hormone in the Treatment of Patients With Cystic Fibrosis

scientific article published on 04 October 2010

Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism.

scientific article published on 21 February 2018

Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis

scientific article published on 01 January 2020

Rivaroxaban versus apixaban in non-valvular atrial fibrillation patients with end-stage renal disease or receiving dialysis

scientific article published on 29 January 2020

Rivaroxaban's Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis

scientific article published on 01 January 2019

Safety and effectiveness of oral factor Xa inhibitors versus warfarin in nonvalvular atrial fibrillation patients at high-risk for falls

scientific article published on 01 October 2019

Systematic Review and Meta-Analysis of Real-World Studies Evaluating Rivaroxaban for Cancer-Associated Venous Thrombosis

scientific article published on 31 March 2018

Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation

scientific article published on February 1, 2012

The Impact of Antiplatelet and Anticoagulant Therapies on Gastrointestinal Symptoms in Patients with Atrial Fibrillation: A Systematic Review

scientific article published on August 28, 2012

The prognostic impact of pre-implantation hyponatremia on morbidity and mortality among patients with left ventricular dysfunction and implantable cardioverter-defibrillators

scientific article published on August 16, 2013

Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban

scientific article published on 22 March 2018